Gennem indførelsen af et supplerende certifikat skulle der kunne gives lægemiddelindustrien i medlemsstater ne samme vilkår som dem, der gælder for visse tredjelandes lægemiddelindustri.
Through the introduction of a supplementary certificate the pharmaceutical industry in the Member States should be placed in a situation similar to that of the pharmaceutical industry in certain third countries.